Search
-
Transforming Research Through Synthetic Data
Synthetic data, powered by AI, is poised to transform the market research industry. The question isn’t if, but when and how.
-
European Observatory of Rare Diseases reveals that Europeans find conditions for patients with rare diseases are unacceptable
ASAP FOR CHILDREN has published the results of its third European Rare Disease Observatory conducted by Ipsos.
-
[Webinar] Gen-AI-Powered Persona Bots: Bringing Healthcare Segmentations to Life
Watch Ipsos’ webinar, "GenAI-Powered Persona Bots: Bringing Healthcare Segmentations to Life
-
Rare Diseases: A Diagnostic Odyssey
Unravelling the Complexities of Rare Diseases: A Market Research Perspective
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
Inspiring Better Healthcare
Commercial success in the healthcare sector means putting the patient at the heart of every decision...
-
A Dose of Digital: Can Pharma Make DTx a Healthy Business?
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
-
Global Healthcare Monitors
Strategically-focused insights from independent data (formerly Syndicated Services)